The UK’s health watchdog has said health professionals can consider digital and mobile interventions as a supplement to regular services to support behaviour change in people at risk of developi
Behavioural science provides a roadmap to understanding how HCPs make decisions and what drives prescribing behaviour, but also, more importantly, it gives us strategies that we can apply t
Behaviour change is set to become a key skill for pharma companies in the very near future – an essential beyond-the-pill strategy, often delivered via digital tech, that can help keep peop
Brian Jepson reviews recent research that points to the need for greater engagement with behavioural science among medical affairs professionals, to inform medical education and engage HCPs.
Outside of a dedicated group of expert users and patient adherence pilot schemes, the ‘softer’ behavioural and social sciences are largely unknown or misunderstood, according to recent researc
As the ASCO congress drew to a close, Johnson & Johnson filed for FDA approval of its BCMA-targeting CAR-T therapy Carvykti for use earlier in the treatment pathway fo
Health systems globally have reached a critical inflexion point, where ageing populations and tightening budgets mean we can no longer continue to purely treat late-stage symptomatic diseas